Inhibiting cancer cell hallmark features through nuclear export inhibition.

Inhibiting cancer cell hallmark features through nuclear export inhibition.
复制标题

通过核输出抑制来抑制癌细胞标志特征

DOI:
10.1038/sigtrans.2016.10
复制
发表时间:
2016
影响因子:
39.3
通讯作者:
Jia D
Jia D
中科院分区:
医学1区
文献类型:
--
作者:
Sun Q;Chen X;Zhou Q;Burstein E;Yang S;Jia D

文献摘要

参考文献

被引文献

相似文献

通过抑制核输出治疗癌症是基础研究转化为临床应用的最佳例子之一。核输出因子染色体区域维持1(CRM 1; Xpo 1和exportin-1)控制细胞定位和许多蛋白质的功能,这些蛋白质对许多癌症标志的发展至关重要。CRM 1的不同作用可能解释了CRM 1抑制剂在临床前研究和/或临床试验(I-III期)中对晚期实体瘤和血液肿瘤的广泛抗癌效力。在这篇综述中,我们比较和对比不同的CRM 1抑制剂的作用机制,并讨论未开发的非共价CRM 1抑制剂的潜在益处。这一新兴领域已经揭示,核输出抑制是一个有吸引力的目标,对低毒性广谱有效的抗癌治疗。
Treating cancer through inhibition of nuclear export is one of the best examples of basic research translation into clinical application. Nuclear export factor chromosomal region maintenance 1 (CRM1; Xpo1 and exportin-1) controls cellular localization and function of numerous proteins that are critical for the development of many cancer hallmarks. The diverse actions of CRM1 are likely to explain the broad ranging anti-cancer potency of CRM1 inhibitors observed in pre-clinical studies and/or clinical trials (phase I–III) on both advanced-stage solid and hematological tumors. In this review, we compare and contrast the mechanisms of action of different CRM1 inhibitors, and discuss the potential benefit of unexplored non-covalent CRM1 inhibitors. This emerging field has uncovered that nuclear export inhibition is well poised as an attractive target towards low-toxicity broad-spectrum potent anti-cancer therapy.
DOI: 10.1053/j.gastro.2012.10.036
发表时间: 2013-02
期刊: Gastroenterology
影响因子: 29.4
作者:
Azmi AS;Aboukameel A;Bao B;Sarkar FH;Philip PA;Kauffman M;Shacham S;Mohammad RM
通讯作者: Mohammad RM
DOI: 10.1016/j.ebiom.2015.07.041
发表时间: 2015-09
期刊: EBioMedicine
影响因子: 11.1
作者:
Boons E;Vanstreels E;Jacquemyn M;Nogueira TC;Neggers JE;Vercruysse T;van den Oord J;Tamir S;Shacham S;Landesman Y;Snoeck R;Pannecouque C;Andrei G;Daelemans D
通讯作者: Daelemans D
DOI: 10.1016/j.bbamcr.2010.10.014
发表时间: 2011-09
期刊: Biochimica et biophysica acta
影响因子: --
作者:
Chook YM;Süel KE
通讯作者: Süel KE
DOI: 10.1186/s12885-015-1790-z
发表时间: 2015-11-17
期刊: BMC cancer
影响因子: 3.8
作者:
Crochiere M;Kashyap T;Kalid O;Shechter S;Klebanov B;Senapedis W;Saint-Martin JR;Landesman Y
通讯作者: Landesman Y
DOI: 10.1371/journal.pone.0076593
发表时间: 2013
期刊: PloS one
影响因子: 3.7
作者:
Beckham TH;Cheng JC;Lu P;Marrison ST;Norris JS;Liu X
通讯作者: Liu X